超分子循环德克斯深度欧性溶剂强化奇托桑欧凝作为一种新的透皮输送系统的复星用于抗牛皮
Bin Li1, Xiaojuan Li1, Shuying Li1
1School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
International journal of biological macromolecules
|January 23, 2025
概括
这项研究开发了一种新型的深度浸泡溶剂 (DES) - - 基托桑 (chitosan) 浸泡溶剂,以改善皮病治疗中的复星 (RES) 输送. 增强的配方有效地减少了小鼠的牛皮症状,为现有疗法提供了有希望的替代方案.
科学领域:
- 材料科学 材料科学 材料科学
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 牛皮需要长期管理,因为它具有慢性炎症性.
- 复星 (RES) 显示出抗牛皮的潜力,但其溶解性,稳定性和皮肤保留性不佳.
- 需要新的药物输送系统来克服 RES 的局限性,以有效治疗牛皮.
研究的目的:
- 开发一种带有白醇的粘合剂eutectogel,使用深度溶解剂 (DES) 和奇托 (CS).
- 为了评估DES增强的eutectogel在一种因米奎莫德诱导的牛皮类小鼠模型中的疗效.
主要方法:
- 通过电静电和键交叉链接制造一个粘合剂eutectogel 循环德氨酸-levulinic 酸DES和奇托.
- 特性和分子动力学模拟以评估DES属性和RES负载.
- 在体内评估,使用一种因米奎莫德诱导的牛皮类似的小鼠模型.
主要成果:
- 该DES增强了白醇的溶解性,稳定性,并在eutectogel中充当交叉链接剂/增塑剂.
- 欧特基凝形成了一个in-situ膜,促进长时间的白醇透到皮肤中.
- 装有RES的eutectogel显著缓解了牛皮的症状,抑制了角质细胞的增殖,并调节了IL-23/IL-17轴因子,性能优于calcipotriol膏.
结论:
- 增强了DES的eutectogel是一个有前途的局部药物输送平台,用于牛皮.
- 这种配方增强了白醇在牛皮管理中的治疗潜力.
- 这项研究扩大了绿色多糖基医疗材料在治疗皮肤疾病中的应用.
相关概念视频
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
01:18Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...